Nuzenio

Metastatic Hormone

Metastatic Hormone news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

company 17 latest news signals 14 publisher sources 100/100 entity strength

Latest news

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - NovartisNovartis · Sat, 08 Aug 2026 12:24:46 GMT HR-Positive Breast Cancer: ctDNA-Guided De-escalation and Clinical Uncertainty - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 07 Aug 2026 12:25:58 GMT Outlining Questions About the Future of HR+ Breast Cancer Care - OncLiveOncLive · Thu, 06 Aug 2026 21:50:00 GMT Approval of Pluvicto® for Metastatic Hormone-Sensitive Prostate Cancer - Oliver Sartor - urotoday.comurotoday.com · Thu, 06 Aug 2026 19:44:56 GMT CAPItello-281 and the PTEN-Deficient Subset of Metastatic Hormone-Sensitive Prostate Cancer - Alicia Morgans - urotoday.comurotoday.com · Thu, 06 Aug 2026 17:23:13 GMT FDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNetSurvivorNet · Tue, 04 Aug 2026 17:34:02 GMT Pluvicto Approved Earlier in Metastatic Prostate Cancer - MedscapeMedscape · Mon, 03 Aug 2026 14:03:57 GMT Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 12:33:04 GMT

Timeline

Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis

Fri, 07 Aug 2026 12:25:58 GMTHR-Positive Breast Cancer: ctDNA-Guided De-escalation and Clinical Uncertainty - The American Journal of Managed Care

Thu, 06 Aug 2026 21:50:00 GMTOutlining Questions About the Future of HR+ Breast Cancer Care - OncLive

Thu, 06 Aug 2026 19:44:56 GMTApproval of Pluvicto® for Metastatic Hormone-Sensitive Prostate Cancer - Oliver Sartor - urotoday.com

Thu, 06 Aug 2026 17:23:13 GMTCAPItello-281 and the PTEN-Deficient Subset of Metastatic Hormone-Sensitive Prostate Cancer - Alicia Morgans - urotoday.com

Tue, 04 Aug 2026 17:34:02 GMTFDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNet

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Pluvicto15 live mentions Sensitive Prostate Cancer10 live mentions PSMA4 live mentions Metastatic Prostate Cancer4 live mentions ARPI4 live mentions FDA3 live mentions Approval3 live mentions Novartis3 live mentions HRR3 live mentions Springer Nature Link3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Metastatic Hormone.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.